New fertility drug QL1012D put to the test against Gonal-F®
NCT ID NCT06864793
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injectable fertility drug (QL1012D) against an approved one (Gonal-F®) in 48 healthy women aged 18-45. The goal is to see if the new drug works the same way in the body and is just as safe. Participants receive both drugs at different times to compare them directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY, FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of Jilin University
Changchun, Jilin, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- IVF Needle-Free? oral pill tested as injection alternative
- Obesity may blunt the Brain's ovulation signal, study hints
- Could a fibroid drug help women with adenomyosis finally achieve a live birth?
- Could a blood injection revive aging ovaries?
- Could a shot of your own blood help your ovaries produce more eggs?
- Blood plasma injection aims to wake up dormant ovaries in menopause